Structural and Functional Evidence for Citicoline Binding and Modulation of 20S Proteasome Activity: Novel Insights into its Pro-Proteostatic Effect.

Structural and Functional Evidence for Citicoline Binding and Modulation of 20S Proteasome Activity: Novel Insights into its Pro-Proteostatic Effect. Biochem Pharmacol. 2020 Apr 13;:113977 Authors: Sbardella D, Coletta A, Tundo GR, Ahmed IMM, Bellia F, Oddon F, Manni G, Coletta M Abstract Citicoline or CDP-choline is a drug, made up by a cytidine 5'-diphosphate moiety and choline, which upon adsorption is rapidly hydrolyzed into cytidine 5'-diphosphate and choline, easily bypassing the blood-brain barrier. Once in the brain, these metabolites are used to re-synthesize citicoline in neurons and in the other cell histotypes which uptake them. Citicoline administration finds broad therapeutic application in the treatment of glaucoma as well as other retinal disorders by virtue of its safety profile and neuro-protective and neuroenhancer activity, which significantly improves the visual function. Further, this molecule finds a therapeutic application in different neurodegenerative disease, delaying the cognitive decline in Alzheimer's Disease (AD) and Parkinson's Disease (PD) subjects. In this work we show that citicoline greatly affects the proteolytic activity of the 20S proteasome, functioning as a bimodal allosteric modulator, likely binding at multiple sites. In silico binding simulations identify several potential binding sites for citicoline on 20S proteasome, and their topology envisages the possibility that, by occupying some of these pockets, citic...
Source: Biochemical Pharmacology - Category: Drugs & Pharmacology Authors: Tags: Biochem Pharmacol Source Type: research

Related Links:

AbstractWhile the pathogenesis of Parkinson ’s disease is not fully understood, there is increasing evidence that inflammatory responses in the brain are implicated in both disease initiation and progression. The inflammatory process in Parkinson’s disease is, however, not limited to the brain but also involves the gastrointestinal tract. High amounts of cytokines and inflammatory markers are found in the colon of Parkinson’s disease patients and there is now strong epidemiological and genetical evidence linking Parkinson’s disease to inflammatory bowel diseases. Recent findings obtained in both exp...
Source: Journal of Neurology - Category: Neurology Source Type: research
Authors: Couturier A, Giocanti-Auregan A, Massin P Abstract Initial management of diabetic macular edema (DME) is well-defined, but there is a lack of national or international consensus for patients who do not respond or respond only partially to these treatments. Several studies, mostly retrospective, have assessed medication switches, but currently, the literature contains no randomized studies. The goal of this article is to present an algorithm for switching medications, which can be proposed to DME patients treated with anti-VEGF agents, as defined by a group of French retina experts, supported by the existin...
Source: Journal Francais d Ophtalmologie - Category: Opthalmology Tags: J Fr Ophtalmol Source Type: research
ABSTRACT Objective Evaluate the accuracy of two semantic categories of the verbal fluency test (supermarket and animal categories) to separate healthy elderly individuals and lower educated Alzheimer ’ s disease patients. Methods We evaluated 69 older adults with less than 5 years of schooling, consisting of 31 healthy elderly, and 38 patients diagnosed with Alzheimer ’ s disease. Semantic verbal fluency was evaluated using the animal and supermarket categories. Mann-Whitney U and Independent t Tests were used to compare the two groups, and the diagnostic accuracy of the tests was analyzed by sensitivity, speci...
Source: Jornal Brasileiro de Psiquiatria - Category: Psychiatry Source Type: research
Dr Christoph Diener on the six recent neurology studies with potential impact on the field.Medscape Neurology
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery Commentary Source Type: news
Olfactory dysfunction could be an early and reliable indicator for the diagnosis of neurodegenerative disorders such as Alzheimer and Parkinson's diseases. In this paper, we compare the potential of different noninvasive medical imaging modalities (optical coherence tomography, confocal microscopy, and fluorescence endomicroscopy) to distinguish how the olfactory epithelium, both at the cellular and the structural levels, is altered. Investigations were carried out on three experimental groups: two pathological groups (mice models with deliberately altered olfactory epithelium and Alzheimer's disease transgenic mice models...
Source: Frontiers in Neuroanatomy - Category: Neurology Source Type: research
An eye implant measuring just 0.2mm by 1mm could revolutionise the treatment of glaucoma, a condition that affects 500,000 Britons and is a leading cause of blindness.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
PARKINSON'S disease can affect the entire body with early warning signs of the degenerative condition appearing anywhere. Noticing a change in the breath could signal early Parkinson's.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Abstract To evaluate functional capacity, mobility and balance in elderly patients with Alzheimer's Disease (AD), in its mild, moderate and severe forms, verifying the existence of correlation among these parameters. Eighty-eight elderly patients (81.79 ± 6.54 years) diagnosed with AD treated at an elderly care reference center in Taguatinga-DF were selected, and information was collected between November 2018 and March 2019. Data collection was initially made by filling in the evaluation form. Subsequently, two questionnaires were administered to caregivers (Clinical Dementia Rating-CDR and Disability Assessment fo...
Source: Revista Brasileira de Cineantropometria e Desempenho Humano - Category: Sports Medicine Source Type: research
Conditions:   Parkinson Disease;   Anxiety;   Depression Intervention:   Behavioral: Mindfulness-based cognitive therapy (MBCT) Sponsors:   University of California, San Francisco;   Mount Zion Health Fund Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Amyotrophic Lateral Sclerosis;   Brainstem Stroke;   Muscular Dystrophies;   Parkinson's Disease and Parkinsonism;   Multiple System Atrophy;   Brain Tumor Adult;   Spinal Cord Injuries;   Locked-in Syndrome Interventions:   Behavioral: BCI-FIT multi-modal access;   Behavioral: BCI-FIT adaptive signal modeling;   Behavioral: BCI-FIT active querying;   Behavioral: BCI-FIT language modeling Sponsor:   Oregon H...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alzheimer's | Brain | Drugs & Pharmacology | Glaucoma | Neuroblastoma | Neurology | Neuroscience | Parkinson's Disease | Science | Vitamin A